Antipsychotics Flashcards

1
Q

Fluphenazine (Prolixin) Dosing

A
Tablet: 1,2.5,5,10mg
Oral Elixir: 2.5mg/5ml
Concentrate: 5mg/ml
Injection (IR): 2.5mg/ml
LA Depot: 25mg/ml
Initiate 2.5-10mg/day Q6-8 hrs; dose range: 1-50mg/day; MAX: 100mg/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fluphenazine (Prolix) Clinical

A

2D6 substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Haloperidol (Haldol) Dosing

A
Tablet: 0.5,1,2,5,10,20mg
Oral Soln: 2mg/ml
Injection (IR): 5mg/ml
LA Depot: 50mg/ml, 100mg/ml
Initiate 1-15mg/day, divide doses if needed, MAX: 100mg/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Haloperidol (Haldol) Clinical

A

2D6, 3A4 substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Loxapine (Loxitane, Adasuve) Dosing

A

Oral inhalation powder: 10mg/dose

10mg dose Q24 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Loxapine (Loxitane, Adasuve) Clinical

A

“Atypical typical”

Adasuve oral inhalation power has REMS - must be in hospital setting w/ emergency service access, CI’d w/ hx of lung disease, monitor closely for bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Perphenazine (Trilafon) Clinical

A

Increased use in recent years due to CATIE study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pimozide (Orap) Clinical

A

3A4 substrate, QTc prolongation limits use, usual clinical use limited to Tourette’s disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thioridazine (Mellaril) Clinical

A

Significant QTc prolongation limits use, not generally initiated as new therapy, informed consent necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thiothixene (Navane) Clinical

A

1A2 substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aripiprazole (Abilify and Abilify Maintena) Dosing

A

Tablet: 2,5,10,15,20,30mg
LA Depot: 300mg/vial, 400mg/vial
Liquid: 1mg/ml
Initiate 10-15mg QD, titrate Q2 weeks, MAX: 30mg/day
IR Injection: 9.75mg IM, 2 hrs between doses, MAX: 3 injections/day
LA Depot: 400mg IM once monthly, overlap w/ oral x2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aripiprazole (Abilify and Abilify Maintena) Clinical

A

2D6, 3A4 substrate
Very long T1/2
FDA approved for MDD in combo with antidepressant (not LAI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aripiprazole lauroxil (Aristada) Dosing

A

LA Depot: 442mg/vial, 662mg/vial, 882mg/vial
Initiate based on oral dose:
10mg QD: 442mg
15mg QD: 662mg
20mg QD: 882 mg
Any dose can be given Q4 weeks, 882mg Q6 weeks if tolerated, MUST overlap oral aripiprazole x3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aripiprazole lauroxil (Aristada) Clinical

A

2D6, 3A4 substrate

LAI dosage form only, dose adjustments for 2D6/3A4 inhibitors and/or 3A4 inducers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Asenapine (Saphris) Dosing

A

Sublingual tablet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Asenapine (Saphris) Clinical

A

1A2 substrate

Must be taken SL, bioavailability improved to 25-30%, must not eat, drink, smoke for 10 min after dose

17
Q

Brexpiprazole (Rexulti) Clinical

A

2D6, 3A4 substrate
Lower risk of akathisia compared to aripiprazole, higher risk of weight gain, dose adjustments for severe hepatic impairments, D2/D3 partial agonist

18
Q

Cariprazine (Vraylar) Clinical

A

3A4 substrate
Greater risk of akathisia vs aripiprazole or brexpiprazole, moderate weight gain, may have serotonin effects for better efficacy in negative symptoms, D2/D3 partial agonist

19
Q

Clozapine (Clozaril, Fazaclo) Dosing

A

Initiate 12.5-25mg/day at bedtime, titrate in increments of 25-50mg/day wkly to target of 300-450mg/day, MAX: 900mg/day, can divide dose for tolerability

20
Q

Clozapine (Clozaril, Fazaclo) Clinical

A

1A2 substrate
WBC/ANC must be monitored wkly x6 months, Q2 wks x6 months, then Q4 wks, maintain ANC above 1500, boxed warning for agranulocytosis, myocarditis, dose-related seizures, and orthostatic hypertension, constipation, weight gain, metabolic syndrome, hypersalivation, Pregnancy B

21
Q

Iloperidone (Fanapt) Dosing

A

Initiate 1mg BID, increase by 2mg/day until target dose: 12-24mg/day, MAX: 24mg/day

22
Q

Iloperidone (Fanapt) Clinical

A

2D6, 3A4 substrate

Titrate slowly due to significant orthostatic hypotension, QTc prolongation

23
Q

Lurasidone (Latuda) Dosing

A

Initiate 40mg QD, MAX: 160mg/day

24
Q

Lurasidone (Latuda) Clinical

A

3A4 substrate

Pregnancy B, must take with food to improve bioavailability and Cmax (400 calorie meal)

25
Q

Olanzapine (Zyprexa) Dosing

A

Initiate 2.5-10mg QD, dose range: 5-20mg/day (may see clinically higher doses)
IR injection: 10mg, MAX: 3 injections Q24 hrs, given 2-4 hrs apart
LA Depot: 150-300mg IM Q2 wks or 405mg IM Q4 wks

26
Q

Olanzapine (Zyprexa) Clinical

A

1A2 substrate
IR injection: Don’t give in same syringe as lorazepam injection: boxed warning for respiratory depression
LA Depot: REMS for PDSS

27
Q

Paliperidone (Invega, Invega Sustenna, Invega Trinza) Dosing

A
ER tablet
LA Depot (Q4 wks): 39,78,117,156,234mg
LA Depot (Q12 wks): 273,410,546,819mg
Initiate 6mg QD, MAX: 12mg/day
LA Depot (Q4 wks): 234mg load, 117mg booster on day 8, maintenance Q5 wks after load, 39-234mg IM Q4 wks
LA Depot (Q12 wks): based on stable 4 wks of Invega Sustenna:
78mg Invega: 273mg Trinza
117mg: 410mg
156mg: 546mg
234mg: 819mg
28
Q

Paliperidone (Invega, Invega Sustenna, Invega Trinza) Clinical

A

Renal elimination, ER leaves ghost tabs, 9-OH metabolite of risperidone
Trinza: specific instructions for vigorous shaking to suspend, important to avoid incomplete suspension

29
Q

Quetiapine (Seroquel) Clinical

A

3A4 substrate
25-50mg used for sleep (NOT RECOMMENDED)
Street use: $1/mg
Recent boxed warning for QTc prolongation

30
Q

Risperidone (Risperdal) Dosing

A

LA depot injection doesn’t provide appreciable serum concentrations until between 2nd and 3rd dose, must overlap oral for efficacy, EPS prominent at doses beginning at 6mg/day

31
Q

Ziprasidone (Geodon) Dosing

A

Initiate 20mg BID WITH FOOD, dose range: 80mg BID, min effective dose: 120mg/day, MAX recommended: 160mg/day, MAX clinically: 240mg/day

32
Q

Ziprasidone (Geodon) Clincal

A

Must be given with food to improve bioavailability (400 calorie meals), clinically given QD with evening meal, QTc prolongation, DRESS